PAMIDRONATE DISODIUM

PAMIDRONATE DISODIUM was reported 3399 times

PAMIDRONATE DISODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TORUS FRACTURE 20 0.2817
1 INFUSION SITE COLDNESS 20 0.2000
2 RENAL INTERSTITIAL FIBROSIS 10 0.1695
3 BONE DEBRIDEMENT 57 0.1180
4 CARDIAC SIDEROSIS 3 0.1111
5 PERIODONTAL DESTRUCTION 4 0.1111
6 GLOMERULONEPHRITIS FOCAL 7 0.1111
7 GAMMA-GLUTAMYLTRANSFERASE DECREASED 20 0.1042
8 HYPERBARIC OXYGEN THERAPY 17 0.1024
9 BONE LESION EXCISION 14 0.0927
10 ACTINOMYCOTIC SKIN INFECTION 3 0.0882
11 SEQUESTRECTOMY 52 0.0781
12 WOUND DEBRIDEMENT 31 0.0742
13 MANDIBULECTOMY 3 0.0682
14 WOUND CLOSURE 13 0.0670
15 VIIITH NERVE LESION 3 0.0652
16 CALLUS FORMATION DELAYED 3 0.0625
17 MAXILLOFACIAL OPERATION 5 0.0575
18 BONE INFECTION 5 0.0562
19 RADIATION FIBROSIS 3 0.0517
20 WOUND TREATMENT 13 0.0506
21 BENCE JONES PROTEINURIA 2 0.0500
22 OSTEOTOMY 15 0.0459
23 ACTINOMYCOSIS 43 0.0449
24 DEBRIDEMENT 33 0.0429
25 HYPERCALCAEMIA OF MALIGNANCY 11 0.0404
26 MINERAL METABOLISM DISORDER 6 0.0377
27 BONE FORMATION DECREASED 6 0.0375
28 DENTAL TREATMENT 9 0.0372
29 ORAL SOFT TISSUE DISORDER 12 0.0358
30 PRIMARY SEQUESTRUM 32 0.0353
31 CALCIUM IONISED DECREASED 8 0.0329
32 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 7 0.0329
33 FAILURE OF IMPLANT 5 0.0312
34 5-HYDROXYINDOLACETIC ACID INCREASED 2 0.0308
35 OSTEOMYELITIS CHRONIC 19 0.0307
36 TUMOUR MARKER ABNORMAL 10 0.0302
37 FOCAL GLOMERULOSCLEROSIS 3 0.0283
38 GASTROENTERITIS RADIATION 9 0.0274
39 POST-TRAUMATIC NECK SYNDROME 20 0.0247
40 BIOPSY BONE ABNORMAL 2 0.0238
41 WATER INTOXICATION 12 0.0237
42 JAW OPERATION 21 0.0236
43 ASEPTIC NECROSIS BONE 18 0.0230
44 PARATHYROID GLAND ENLARGEMENT 3 0.0210
45 BONE METABOLISM DISORDER 6 0.0199
46 DENTURE WEARER 5 0.0193
47 OSTEOPETROSIS 3 0.0191
48 ASPERGILLOMA 6 0.0187
49 NEPHROCALCINOSIS 21 0.0177
50 OSTEONECROSIS OF JAW 435 0.0176
51 BONE DENSITY INCREASED 7 0.0175
52 METASTASES TO SKIN 18 0.0174
53 ABSCESS JAW 18 0.0173
54 POSTOPERATIVE INFECTION 8 0.0169
55 OSTEONECROSIS 534 0.0162
56 INFESTATION 4 0.0154
57 PLASTIC SURGERY 5 0.0154
58 ATYPICAL FEMUR FRACTURE 42 0.0149
59 ORAL CAVITY FISTULA 7 0.0143
60 CYTOMEGALOVIRUS GASTROENTERITIS 3 0.0139
61 EXCESSIVE GRANULATION TISSUE 11 0.0136
62 INFUSION SITE INDURATION 20 0.0135
63 TOOTH EXTRACTION 168 0.0135
64 MULTIPLE MYELOMA 59 0.0126
65 BONE SWELLING 12 0.0124
66 LIFE EXPECTANCY SHORTENED 7 0.0123
67 OSTEOSCLEROSIS 19 0.0121
68 BONE DEFORMITY 8 0.0119
69 POST PROCEDURAL DIARRHOEA 6 0.0118
70 SCAPULA FRACTURE 6 0.0115
71 INFUSION SITE THROMBOSIS 3 0.0112
72 EXPOSED BONE IN JAW 24 0.0111
73 GASTROINTESTINAL TRACT ADENOMA 4 0.0110
74 MEAN CELL HAEMOGLOBIN DECREASED 20 0.0109
75 BIOPSY KIDNEY ABNORMAL 2 0.0103
76 ASPIRATION JOINT 2 0.0101
77 PROSTHESIS IMPLANTATION 3 0.0099
78 BONE DISORDER 173 0.0095
79 BONE SCAN ABNORMAL 4 0.0094
80 CARCINOID TUMOUR 7 0.0094
81 BIOPSY BONE MARROW ABNORMAL 4 0.0088
82 OSTEOLYSIS 18 0.0088
83 LYMPHANGITIS 7 0.0087
84 PELVIC NEOPLASM 3 0.0087
85 OSTEOGENESIS IMPERFECTA 5 0.0086
86 OSTEITIS 21 0.0083
87 HYPERPARATHYROIDISM PRIMARY 3 0.0082
88 PLASMACYTOMA 15 0.0081
89 RENAL TUBULAR ATROPHY 7 0.0079
90 VASODILATATION 20 0.0079
91 GLOMERULOSCLEROSIS 5 0.0079
92 BLOOD PARATHYROID HORMONE INCREASED 23 0.0079
93 CHONDROCALCINOSIS PYROPHOSPHATE 6 0.0078
94 JUVENILE IDIOPATHIC ARTHRITIS 19 0.0078
95 ADAMTS13 ACTIVITY DECREASED 2 0.0077
96 SKIN SENSITISATION 8 0.0077
97 BONE LESION 27 0.0075
98 MACROGLOSSIA 4 0.0073
99 ORAL SURGERY 17 0.0073
100 DENTAL FISTULA 3 0.0072
101 PURULENCE 14 0.0072
102 FOETAL HEART RATE DECELERATION ABNORMALITY 5 0.0071
103 COMPUTERISED TOMOGRAM ABNORMAL 16 0.0071
104 GINGIVAL ERYTHEMA 6 0.0069
105 JAW DISORDER 38 0.0069
106 GLOMERULONEPHRITIS MINIMAL LESION 5 0.0069
107 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 11 0.0069
108 GINGIVAL ULCERATION 5 0.0066
109 PYOGENIC GRANULOMA 3 0.0064
110 GINGIVAL INFECTION 5 0.0062
111 DENTAL IMPLANTATION 10 0.0061
112 SCLERAL DISCOLOURATION 4 0.0061
113 ACANTHOSIS 2 0.0061
114 RESORPTION BONE INCREASED 5 0.0061
115 INFUSION SITE HAEMORRHAGE 20 0.0061
116 TIBIA FRACTURE 28 0.0060
117 PERIODONTAL DISEASE 8 0.0057
118 ANAEMIA MACROCYTIC 12 0.0056
119 BLOOD IMMUNOGLOBULIN A INCREASED 3 0.0056
120 PARATHYROID TUMOUR BENIGN 4 0.0054
121 HYPERCALCAEMIA 66 0.0053
122 BLOOD CULTURE POSITIVE 16 0.0053
123 MONOCLONAL IMMUNOGLOBULIN PRESENT 4 0.0053
124 RADIATION NECROSIS 3 0.0052
125 HYPOPARATHYROIDISM 4 0.0052
126 HEPATIC MASS 10 0.0052
127 STRESS FRACTURE 28 0.0052
128 HYPERPARATHYROIDISM SECONDARY 13 0.0052
129 PATHOLOGICAL FRACTURE 26 0.0051
130 FRACTURE NONUNION 7 0.0051
131 BLOOD CREATININE DECREASED 16 0.0051
132 JAW FRACTURE 11 0.0051
133 WOUND DEHISCENCE 17 0.0050
134 LYMPHATIC DISORDER 3 0.0050
135 PLACENTAL INSUFFICIENCY 4 0.0050
136 HEPATITIS B 30 0.0050
137 PALATAL DISORDER 3 0.0050
138 PURULENT DISCHARGE 21 0.0049
139 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
140 DENTAL OPERATION 12 0.0049
141 OSTEOMYELITIS 87 0.0048
142 STEM CELL TRANSPLANT 12 0.0048
143 APPARENT LIFE THREATENING EVENT 2 0.0047
144 MITRAL VALVE CALCIFICATION 3 0.0047
145 ABSCESS DRAINAGE 4 0.0046
146 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
147 INFUSION SITE MASS 5 0.0046
148 NEPHROSCLEROSIS 5 0.0045
149 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 4 0.0045
150 HYPERPLASIA 4 0.0044
151 METASTASES TO BONE 73 0.0044
152 CYST RUPTURE 3 0.0044
153 VEIN DISORDER 22 0.0044
154 NEUTROPENIC COLITIS 9 0.0043
155 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 33 0.0042
156 TRYPTASE INCREASED 3 0.0042
157 PERIODONTITIS 9 0.0042
158 PAIN IN JAW 115 0.0041
159 BLOOD PARATHYROID HORMONE DECREASED 6 0.0040
160 MALIGNANT MELANOMA IN SITU 5 0.0040
161 BLADDER OBSTRUCTION 2 0.0039
162 AORTIC ARTERIOSCLEROSIS 10 0.0039
163 HYPOCALCAEMIA 73 0.0039
164 TETANY 7 0.0038
165 INTERVERTEBRAL DISC SPACE NARROWING 3 0.0037
166 LOOSE TOOTH 12 0.0037
167 BONE NEOPLASM 4 0.0037
168 IIIRD NERVE PARALYSIS 3 0.0037
169 NEPHROTIC SYNDROME 25 0.0036
170 SYSTEMIC INFECTION 6 0.0036
171 SUPERFICIAL VEIN THROMBOSIS 3 0.0036
172 FRACTURE DELAYED UNION 3 0.0036
173 TUMOUR MARKER INCREASED 17 0.0035
174 IMPAIRED HEALING 113 0.0034
175 AORTIC CALCIFICATION 2 0.0034
176 KYPHOSIS 6 0.0034
177 ADENOMYOSIS 2 0.0034
178 ORAL INFECTION 13 0.0033
179 DEFORMITY 31 0.0033
180 SOFT TISSUE INFECTION 6 0.0033
181 LOBAR PNEUMONIA 6 0.0032
182 HELICOBACTER GASTRITIS 4 0.0032
183 PUSTULAR PSORIASIS 11 0.0032
184 SOLAR LENTIGO 3 0.0032
185 KLEBSIELLA BACTERAEMIA 3 0.0032
186 BONE MARROW DEPRESSION 3 0.0031
187 SUBCUTANEOUS EMPHYSEMA 3 0.0031
188 ONYCHALGIA 3 0.0030
189 MUCOSAL ULCERATION 3 0.0030
190 ABSCESS NECK 2 0.0030
191 BONE MARROW OEDEMA 3 0.0029
192 CHEST INJURY 6 0.0029
193 STREPTOCOCCAL INFECTION 16 0.0029
194 ASTERIXIS 3 0.0028
195 VASCULAR CALCIFICATION 3 0.0028
196 BODY TEMPERATURE DECREASED 27 0.0027
197 CANDIDIASIS 11 0.0027
198 LARGE INTESTINAL OBSTRUCTION 6 0.0027
199 PULMONARY GRANULOMA 3 0.0026
200 FEMUR FRACTURE 80 0.0026
201 FISTULA 29 0.0026
202 PSEUDOMONAS INFECTION 22 0.0026
203 TOOTH ABSCESS 26 0.0026
204 TOOTHACHE 46 0.0025
205 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 6 0.0025
206 GINGIVITIS 13 0.0024
207 RENAL ATROPHY 3 0.0024
208 NEPHRITIS INTERSTITIAL 3 0.0024
209 NEUROPATHY 4 0.0024
210 METASTASES TO LUNG 27 0.0023
211 ADENOMA BENIGN 2 0.0023
212 INFUSION SITE BRUISING 5 0.0023
213 RETINAL DETACHMENT 21 0.0023
214 METASTASES TO MENINGES 5 0.0022
215 EXTRAVASATION 9 0.0022
216 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
217 H1N1 INFLUENZA 3 0.0021
218 ADENOCARCINOMA OF COLON 4 0.0021
219 SPINAL PAIN 25 0.0021
220 POOR VENOUS ACCESS 22 0.0021
221 METASTASES TO SPINE 7 0.0021
222 ATELECTASIS 20 0.0021
223 BREATH ODOUR 5 0.0020
224 SECOND PRIMARY MALIGNANCY 17 0.0020
225 BLOOD CREATINE INCREASED 9 0.0020
226 LOW TURNOVER OSTEOPATHY 8 0.0020
227 THROMBOPHLEBITIS 7 0.0020
228 HYPOPHAGIA 51 0.0020
229 INCONTINENCE 21 0.0020
230 MASTICATION DISORDER 6 0.0020
231 PHYSICAL DECONDITIONING 5 0.0019
232 HYPERPARATHYROIDISM 4 0.0019
233 ORAL MUCOSAL ERYTHEMA 3 0.0019
234 HAEMODIALYSIS 16 0.0019
235 DILATATION VENTRICULAR 4 0.0019
236 PERIPHERAL COLDNESS 26 0.0019
237 BLOOD ALBUMIN DECREASED 15 0.0019
238 ORTHOPNOEA 6 0.0019
239 METASTASES TO LIVER 33 0.0019
240 COMPRESSION FRACTURE 10 0.0019
241 COSTOCHONDRITIS 3 0.0018
242 OPTIC ATROPHY 3 0.0018
243 INVASIVE DUCTAL BREAST CARCINOMA 5 0.0018
244 BLOOD CALCIUM INCREASED 16 0.0018
245 ORAL CANDIDIASIS 24 0.0018
246 GINGIVAL DISORDER 7 0.0018
247 SPINAL COMPRESSION FRACTURE 15 0.0018
248 GINGIVAL SWELLING 8 0.0018
249 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
250 CEREBRAL ATROPHY 7 0.0018
251 FEMORAL NECK FRACTURE 9 0.0018
252 SENSITIVITY OF TEETH 3 0.0017
253 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
254 KIDNEY FIBROSIS 3 0.0017
255 ESCHERICHIA INFECTION 14 0.0017
256 LUNG INFILTRATION 15 0.0017
257 BLOOD POTASSIUM INCREASED 27 0.0017
258 ENTEROCOCCAL INFECTION 8 0.0017
259 THROMBOPHLEBITIS SUPERFICIAL 5 0.0016
260 METASTATIC RENAL CELL CARCINOMA 3 0.0016
261 TRICUSPID VALVE INCOMPETENCE 13 0.0016
262 CALCIPHYLAXIS 3 0.0016
263 HYPOPHOSPHATAEMIA 12 0.0016
264 NEOPLASM PROGRESSION 56 0.0016
265 GASTRITIS 42 0.0016
266 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
267 IRIDOCYCLITIS 5 0.0016
268 HYPOREFLEXIA 3 0.0016
269 MEAN CELL VOLUME INCREASED 4 0.0016
270 IMMUNODEFICIENCY 23 0.0015
271 ACTINIC KERATOSIS 4 0.0015
272 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
273 CONCOMITANT DISEASE PROGRESSION 3 0.0015
274 TOOTH DISORDER 33 0.0015
275 METASTASES TO LYMPH NODES 10 0.0015
276 BLOOD PHOSPHORUS INCREASED 4 0.0015
277 ARTHRITIS BACTERIAL 6 0.0015
278 VENOUS THROMBOSIS LIMB 3 0.0015
279 ATRIAL THROMBOSIS 3 0.0014
280 GRANULOMA 5 0.0014
281 ABSCESS 23 0.0014
282 PLASMA CELL MYELOMA 56 0.0014
283 MALIGNANT NEOPLASM PROGRESSION 146 0.0014
284 RENAL TUBULAR DISORDER 4 0.0014
285 TYPE I HYPERSENSITIVITY 5 0.0014
286 BRONCHIOLITIS 5 0.0014
287 TORTICOLLIS 3 0.0014
288 HAEMATOCRIT DECREASED 28 0.0014
289 METASTASIS 10 0.0014
290 HEART VALVE INCOMPETENCE 4 0.0014
291 LYMPHOCYTOSIS 3 0.0014
292 RETINAL VEIN OCCLUSION 4 0.0014
293 PARAPLEGIA 4 0.0014
294 GINGIVAL PAIN 11 0.0014
295 BLOOD DISORDER 11 0.0014
296 TUMOUR LYSIS SYNDROME 12 0.0014
297 TRISMUS 7 0.0014
298 INFUSION SITE REACTION 4 0.0013
299 BONE PAIN 78 0.0013
300 ASTIGMATISM 2 0.0013
301 ANOREXIA 17 0.0013
302 FOOT FRACTURE 25 0.0013
303 RENAL FAILURE CHRONIC 10 0.0013
304 MUCOSAL INFLAMMATION 34 0.0013
305 RENAL FAILURE ACUTE 55 0.0013
306 DIASTOLIC DYSFUNCTION 4 0.0013
307 PATELLA FRACTURE 3 0.0013
308 WOUND SECRETION 5 0.0013
309 BREAST CANCER RECURRENT 4 0.0013
310 DENTAL CARIES 14 0.0013
311 URINARY TRACT OBSTRUCTION 3 0.0013
312 NAIL DISORDER 11 0.0013
313 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
314 HUMERUS FRACTURE 6 0.0012
315 ORAL INTAKE REDUCED 3 0.0012
316 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
317 OEDEMA MOUTH 4 0.0012
318 DERMAL CYST 3 0.0012
319 HYPOMAGNESAEMIA 17 0.0012
320 BREAST CANCER METASTATIC 13 0.0012
321 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0012
322 POTENTIATING DRUG INTERACTION 4 0.0012
323 ENDODONTIC PROCEDURE 3 0.0012
324 NEOPLASM RECURRENCE 4 0.0012
325 HEPATIC CYST 4 0.0012
326 AORTIC VALVE INCOMPETENCE 5 0.0012
327 DRUG TOXICITY 16 0.0012
328 POOR PERIPHERAL CIRCULATION 5 0.0012
329 PHLEBITIS 6 0.0012
330 WOUND COMPLICATION 4 0.0012
331 LIVER FUNCTION TEST INCREASED 25 0.0012
332 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
333 HYPOALBUMINAEMIA 9 0.0012
334 HEPATIC LESION 5 0.0012
335 VENTRICULAR DYSFUNCTION 3 0.0012
336 TENDERNESS 12 0.0012
337 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
338 ONYCHOMYCOSIS 5 0.0011
339 RADICULOPATHY 3 0.0011
340 IMMUNOSUPPRESSION 10 0.0011
341 NASAL DISORDER 3 0.0011
342 HEPATOTOXICITY 25 0.0011
343 WEIGHT BEARING DIFFICULTY 3 0.0011
344 PROTEINURIA 21 0.0011
345 RASH PUSTULAR 8 0.0011
346 LUMBAR VERTEBRAL FRACTURE 5 0.0011
347 HYPERKERATOSIS 6 0.0011
348 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
349 NECROSIS 6 0.0011
350 NECK MASS 3 0.0011
351 MITRAL VALVE INCOMPETENCE 12 0.0011
352 LIP PAIN 3 0.0010
353 RHINOVIRUS INFECTION 4 0.0010
354 LUMBAR SPINAL STENOSIS 3 0.0010
355 HYPERTRIGLYCERIDAEMIA 6 0.0010
356 SPINAL OSTEOARTHRITIS 9 0.0010
357 GROWTH RETARDATION 3 0.0010
358 CREPITATIONS 3 0.0010
359 NEUTROPHIL COUNT DECREASED 41 0.0010
360 HYPERNATRAEMIA 5 0.0010
361 PROTEIN URINE PRESENT 5 0.0010
362 BLOOD CREATININE INCREASED 65 0.0010
363 CHEST X-RAY ABNORMAL 3 0.0010
364 FIBROSIS 3 0.0010
365 PERIPHERAL VASCULAR DISORDER 5 0.0010
366 PHARYNGITIS 12 0.0010
367 FAILURE TO THRIVE 5 0.0010
368 ORAL DISORDER 7 0.0010
369 INFUSION SITE SWELLING 6 0.0010
370 FRACTURE 18 0.0009
371 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
372 HYPERGLYCAEMIA 34 0.0009
373 INFUSION SITE PAIN 12 0.0009
374 EAR PAIN 18 0.0009
375 MULTI-ORGAN FAILURE 16 0.0009
376 RIB FRACTURE 19 0.0009
377 INFECTION 133 0.0009
378 RENAL TUBULAR NECROSIS 9 0.0009
379 CONJUNCTIVITIS 17 0.0009
380 TOOTH INFECTION 12 0.0009
381 MOUTH ULCERATION 19 0.0009
382 RHINITIS ALLERGIC 4 0.0009
383 FACIAL PAIN 8 0.0009
384 PLANTAR FASCIITIS 3 0.0009
385 OEDEMA PERIPHERAL 109 0.0009
386 ORAL PAIN 20 0.0009
387 ADENOCARCINOMA 2 0.0009
388 UNRESPONSIVE TO STIMULI 23 0.0009
389 ULCER 14 0.0009
390 BRONCHOPNEUMONIA 3 0.0009
391 CARDIAC VALVE DISEASE 5 0.0009
392 JOINT EFFUSION 6 0.0009
393 VIITH NERVE PARALYSIS 3 0.0009
394 MICTURITION DISORDER 3 0.0009
395 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
396 ARTHRITIS INFECTIVE 4 0.0009
397 SPINAL COLUMN STENOSIS 4 0.0008
398 COLITIS MICROSCOPIC 4 0.0008
399 PRE-ECLAMPSIA 4 0.0008
400 POLYNEUROPATHY 10 0.0008
401 CANDIDA INFECTION 14 0.0008
402 COMPLICATION ASSOCIATED WITH DEVICE 12 0.0008
403 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
404 BREATH SOUNDS ABNORMAL 4 0.0008
405 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
406 SCOLIOSIS 5 0.0008
407 HYPOKALAEMIA 37 0.0008
408 BONE MARROW FAILURE 16 0.0008
409 CLAVICLE FRACTURE 3 0.0008
410 BLOOD UREA INCREASED 13 0.0008
411 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
412 BLOOD CHOLESTEROL INCREASED 36 0.0008
413 PELVIC FRACTURE 6 0.0008
414 SPINAL CORD COMPRESSION 3 0.0008
415 ARTERIOSCLEROSIS 7 0.0007
416 SPINAL DISORDER 7 0.0007
417 PNEUMONITIS 20 0.0007
418 OESOPHAGITIS 8 0.0007
419 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
420 ECCHYMOSIS 5 0.0007
421 TOOTH FRACTURE 8 0.0007
422 NEUROPATHY PERIPHERAL 69 0.0007
423 TOOTH LOSS 15 0.0007
424 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
425 CONGESTIVE CARDIOMYOPATHY 3 0.0007
426 FEELING COLD 20 0.0007
427 ANGIOPATHY 4 0.0007
428 INFUSION SITE ERYTHEMA 6 0.0007
429 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
430 HYPERPYREXIA 3 0.0007
431 BUNDLE BRANCH BLOCK LEFT 3 0.0007
432 PLEURAL EFFUSION 43 0.0007
433 CHOLECYSTITIS ACUTE 4 0.0007
434 INTERVERTEBRAL DISC DISORDER 3 0.0007
435 VITAMIN D DECREASED 6 0.0007
436 BLOOD MAGNESIUM DECREASED 6 0.0007
437 SKIN ATROPHY 4 0.0007
438 CARDIAC MURMUR 6 0.0007
439 DIVERTICULUM INTESTINAL 3 0.0007
440 PAIN 421 0.0007
441 HYPOVOLAEMIA 4 0.0007
442 PARONYCHIA 3 0.0007
443 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
444 PHYSICAL DISABILITY 3 0.0007
445 DECREASED INTEREST 4 0.0007
446 ISCHAEMIC STROKE 12 0.0007
447 ODYNOPHAGIA 4 0.0007
448 HYDRONEPHROSIS 5 0.0007
449 BREAST CANCER 62 0.0007
450 PAPILLOEDEMA 3 0.0007
451 PANCYTOPENIA 37 0.0007
452 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
453 ABDOMINAL HERNIA 3 0.0007
454 RESPIRATORY DISTRESS 18 0.0007
455 CARDIOMEGALY 8 0.0006
456 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
457 GASTRITIS EROSIVE 3 0.0006
458 EJECTION FRACTION DECREASED 10 0.0006
459 PERFORMANCE STATUS DECREASED 3 0.0006
460 DIALYSIS 9 0.0006
461 FEBRILE NEUTROPENIA 42 0.0006
462 RENAL CYST 5 0.0006
463 ATRIAL FLUTTER 5 0.0006
464 BLOOD CALCIUM DECREASED 7 0.0006
465 ROAD TRAFFIC ACCIDENT 26 0.0006
466 HEPATIC FUNCTION ABNORMAL 23 0.0006
467 ORAL HERPES 12 0.0006
468 DRUG INTOLERANCE 59 0.0006
469 HYPOGAMMAGLOBULINAEMIA 4 0.0006
470 PERICARDIAL EFFUSION 14 0.0006
471 INFLAMMATION 31 0.0006
472 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
473 FLUID INTAKE REDUCED 3 0.0006
474 THROMBOCYTOPENIA 67 0.0006
475 SPINAL FRACTURE 12 0.0006
476 OSTEOPENIA 9 0.0006
477 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
478 SEPSIS 66 0.0006
479 TOE AMPUTATION 3 0.0006
480 WEIGHT LOSS POOR 3 0.0006
481 CACHEXIA 3 0.0006
482 CEREBRAL ISCHAEMIA 3 0.0006
483 LYMPHOEDEMA 4 0.0006
484 PERIORBITAL OEDEMA 3 0.0006
485 STOMATITIS 35 0.0006
486 NO THERAPEUTIC RESPONSE 7 0.0006
487 ANHEDONIA 15 0.0006
488 DEEP VEIN THROMBOSIS 37 0.0006
489 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
490 OSTEOPOROSIS 23 0.0006
491 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
492 MYELODYSPLASTIC SYNDROME 8 0.0006
493 DERMATITIS BULLOUS 4 0.0006
494 NORMAL NEWBORN 3 0.0006
495 MOUTH HAEMORRHAGE 4 0.0005
496 INTESTINAL ISCHAEMIA 3 0.0005
497 BONE DENSITY DECREASED 17 0.0005
498 INTRACRANIAL PRESSURE INCREASED 3 0.0005
499 ERYTHEMA MULTIFORME 5 0.0005
500 NIGHT SWEATS 17 0.0005
501 HAEMOGLOBIN DECREASED 54 0.0005
502 DISEASE PROGRESSION 62 0.0005
503 HYPERTHERMIA 4 0.0005
504 ACIDOSIS 4 0.0005
505 HIP ARTHROPLASTY 8 0.0005
506 LETHARGY 30 0.0005
507 BLOOD URIC ACID INCREASED 3 0.0005
508 SINUS BRADYCARDIA 5 0.0005
509 MUSCULOSKELETAL CHEST PAIN 8 0.0005
510 APNOEA 4 0.0005
511 PULMONARY HAEMORRHAGE 4 0.0005
512 ACUTE MYOCARDIAL INFARCTION 15 0.0005
513 PSYCHOTIC DISORDER 15 0.0005
514 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
515 FEELING HOT 31 0.0005
516 ORAL DISCOMFORT 7 0.0005
517 PROTHROMBIN TIME PROLONGED 3 0.0005
518 LEUKOCYTOSIS 9 0.0005
519 PLATELET COUNT DECREASED 53 0.0005
520 INGUINAL HERNIA 3 0.0005
521 SINUS TACHYCARDIA 7 0.0005
522 DECUBITUS ULCER 4 0.0005
523 POLYURIA 4 0.0005
524 MULTIPLE FRACTURES 8 0.0005
525 STAPHYLOCOCCAL INFECTION 16 0.0005
526 OLIGURIA 3 0.0005
527 BACTERIAL INFECTION 9 0.0005
528 INFUSION SITE EXTRAVASATION 3 0.0005
529 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
530 DYSPNOEA EXERTIONAL 18 0.0005
531 ATRIAL FIBRILLATION 46 0.0005
532 SLEEP APNOEA SYNDROME 9 0.0005
533 PULMONARY MASS 7 0.0005
534 ABSCESS LIMB 2 0.0005
535 BODY HEIGHT DECREASED 5 0.0005
536 RENAL FAILURE 62 0.0005
537 GENERAL PHYSICAL HEALTH DETERIORATION 54 0.0005
538 DEHYDRATION 62 0.0005
539 DYSURIA 17 0.0005
540 ANAEMIA 88 0.0005
541 ORTHOSTATIC HYPOTENSION 8 0.0005
542 LOCAL SWELLING 8 0.0005
543 NEPHROLITHIASIS 21 0.0005
544 DISABILITY 9 0.0005
545 WALKING AID USER 3 0.0005
546 INTERSTITIAL LUNG DISEASE 22 0.0005
547 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
548 INFLUENZA LIKE ILLNESS 37 0.0004
549 MENINGITIS 3 0.0004
550 NERVOUS SYSTEM DISORDER 14 0.0004
551 BREAST MASS 3 0.0004
552 CONTUSION 43 0.0004
553 SURGERY 26 0.0004
554 UVEITIS 6 0.0004
555 BODY TEMPERATURE INCREASED 9 0.0004
556 METABOLIC ACIDOSIS 14 0.0004
557 MICTURITION URGENCY 5 0.0004
558 CELLULITIS 22 0.0004
559 BLOOD PRESSURE DECREASED 29 0.0004
560 RESPIRATORY ARREST 12 0.0004
561 INCREASED TENDENCY TO BRUISE 4 0.0004
562 UROSEPSIS 4 0.0004
563 GRAND MAL CONVULSION 4 0.0004
564 LARGE INTESTINE POLYP 3 0.0004
565 PULMONARY HYPERTENSION 9 0.0004
566 MASS 6 0.0004
567 SPLENOMEGALY 5 0.0004
568 BACK PAIN 99 0.0004
569 PAPULE 3 0.0004
570 OEDEMA 23 0.0004
571 HEPATOCELLULAR INJURY 6 0.0004
572 DIVERTICULUM 3 0.0004
573 COAGULOPATHY 7 0.0004
574 LEUKOPENIA 21 0.0004
575 RED BLOOD CELL COUNT DECREASED 12 0.0004
576 GRAFT VERSUS HOST DISEASE 3 0.0004
577 HYPERCHOLESTEROLAEMIA 4 0.0004
578 LOCALISED INFECTION 10 0.0004
579 NOCTURIA 5 0.0004
580 NEUTROPENIA 56 0.0004
581 POLLAKIURIA 17 0.0004
582 SWELLING 38 0.0004
583 INJECTION SITE MASS 15 0.0004
584 WEIGHT DECREASED 112 0.0004
585 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
586 PYREXIA 138 0.0004
587 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
588 HYPOAESTHESIA ORAL 6 0.0004
589 EMPHYSEMA 4 0.0004
590 TROPONIN INCREASED 3 0.0004
591 HYPOAESTHESIA 59 0.0004
592 CHILLS 46 0.0004
593 NEUTROPHIL COUNT INCREASED 4 0.0004
594 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
595 EMOTIONAL DISORDER 12 0.0004
596 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
597 HIATUS HERNIA 5 0.0004
598 PNEUMONIA 125 0.0004
599 PETECHIAE 4 0.0004
600 DRUG EXPOSURE DURING PREGNANCY 13 0.0004
601 RENAL IMPAIRMENT 32 0.0004
602 PULMONARY OEDEMA 17 0.0004
603 PNEUMOTHORAX 6 0.0004
604 MOVEMENT DISORDER 12 0.0004
605 SENSORY LOSS 3 0.0004
606 RESPIRATORY FAILURE 27 0.0004
607 RESPIRATORY DISORDER 11 0.0004
608 PULMONARY THROMBOSIS 4 0.0004
609 HYPERAESTHESIA 3 0.0004
610 PULMONARY FIBROSIS 7 0.0004
611 SKIN LESION 10 0.0004
612 POST PROCEDURAL COMPLICATION 7 0.0004
613 APHASIA 11 0.0004
614 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
615 ACUTE CORONARY SYNDROME 3 0.0004
616 HAEMORRHOIDS 7 0.0004
617 MALNUTRITION 4 0.0004
618 MYOCARDIAL ISCHAEMIA 4 0.0004
619 SINUSITIS 36 0.0004
620 SCAR 6 0.0004
621 SKIN HYPERPIGMENTATION 3 0.0003
622 ANURIA 3 0.0003
623 PULMONARY EMBOLISM 33 0.0003
624 DELIRIUM 12 0.0003
625 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
626 ELECTROLYTE IMBALANCE 4 0.0003
627 CAESAREAN SECTION 4 0.0003
628 EOSINOPHILIA 6 0.0003
629 LYMPHADENOPATHY 12 0.0003
630 CARDIOMYOPATHY 5 0.0003
631 RESPIRATORY RATE INCREASED 3 0.0003
632 MYOCLONUS 4 0.0003
633 HYPERLIPIDAEMIA 4 0.0003
634 FLUSHING 34 0.0003
635 HAEMORRHAGE INTRACRANIAL 5 0.0003
636 BLOOD BILIRUBIN INCREASED 9 0.0003
637 BONE LOSS 5 0.0003
638 OPTIC NEURITIS 3 0.0003
639 C-REACTIVE PROTEIN INCREASED 12 0.0003
640 EXOSTOSIS 3 0.0003
641 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
642 OVARIAN CANCER 3 0.0003
643 SMALL INTESTINAL OBSTRUCTION 4 0.0003
644 THYROID DISORDER 5 0.0003
645 MENTAL STATUS CHANGES 9 0.0003
646 HAEMOPTYSIS 9 0.0003
647 CYST 4 0.0003
648 DEMENTIA 9 0.0003
649 HEPATIC ENCEPHALOPATHY 3 0.0003
650 HYPONATRAEMIA 18 0.0003
651 BLOOD SODIUM DECREASED 6 0.0003
652 OCULAR HYPERAEMIA 15 0.0003
653 MUSCLE ATROPHY 4 0.0003
654 LIVER DISORDER 14 0.0003
655 INTRAOCULAR PRESSURE INCREASED 4 0.0003
656 DRUG RESISTANCE 8 0.0003
657 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
658 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
659 CONFUSIONAL STATE 50 0.0003
660 DIZZINESS POSTURAL 3 0.0003
661 THROMBOTIC MICROANGIOPATHY 3 0.0003
662 ANGINA UNSTABLE 2 0.0003
663 VITAMIN D DEFICIENCY 3 0.0003
664 OSTEOARTHRITIS 13 0.0003
665 HEPATOMEGALY 3 0.0003
666 MUSCLE SPASMS 56 0.0003
667 PARAESTHESIA 48 0.0003
668 BEDRIDDEN 4 0.0003
669 MIGRAINE 29 0.0003
670 CHEST PAIN 56 0.0003
671 CATARACT 18 0.0003
672 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
673 UPPER LIMB FRACTURE 6 0.0003
674 BLOOD POTASSIUM DECREASED 9 0.0003
675 HEPATIC FAILURE 9 0.0003
676 FULL BLOOD COUNT DECREASED 6 0.0003
677 ASTHENIA 111 0.0003
678 DYSPHAGIA 28 0.0003
679 SUBARACHNOID HAEMORRHAGE 3 0.0003
680 CONSTIPATION 64 0.0003
681 GINGIVAL BLEEDING 4 0.0003
682 EAR DISCOMFORT 3 0.0003
683 GASTROINTESTINAL DISORDER 26 0.0003
684 SYNCOPE 29 0.0003
685 HYPERBILIRUBINAEMIA 3 0.0003
686 VENTRICULAR EXTRASYSTOLES 3 0.0003
687 HYPERTENSION 61 0.0003
688 INFLUENZA 32 0.0003
689 INFUSION RELATED REACTION 19 0.0003
690 HYPOXIA 10 0.0003
691 SKIN REACTION 4 0.0003
692 SUDDEN DEATH 3 0.0003
693 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
694 LYMPHOPENIA 4 0.0003
695 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
696 HERPES ZOSTER 16 0.0003
697 ABDOMINAL DISTENSION 29 0.0003
698 SYNOVITIS 5 0.0003
699 PARAESTHESIA ORAL 4 0.0003
700 FAECES DISCOLOURED 6 0.0003
701 HAEMATEMESIS 7 0.0003
702 HYPOKINESIA 4 0.0003
703 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
704 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
705 CHOLELITHIASIS 9 0.0003
706 INJECTION SITE SWELLING 21 0.0003
707 ANXIETY 78 0.0003
708 ASPIRATION 3 0.0003
709 ASCITES 8 0.0003
710 VISUAL ACUITY REDUCED 9 0.0003
711 FOOT DEFORMITY 3 0.0003
712 INJURY 19 0.0003
713 URINARY INCONTINENCE 8 0.0003
714 DIPLOPIA 7 0.0003
715 INTESTINAL PERFORATION 3 0.0003
716 NEPHROPATHY TOXIC 3 0.0003
717 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
718 HEART RATE IRREGULAR 6 0.0003
719 GASTRIC ULCER 5 0.0003
720 NEOPLASM 3 0.0003
721 GLAUCOMA 5 0.0003
722 ERUCTATION 5 0.0003
723 ANKLE FRACTURE 4 0.0003
724 APHTHOUS ULCER 2 0.0003
725 VASCULITIS 3 0.0003
726 LUNG INFECTION 4 0.0003
727 BRONCHITIS 19 0.0003
728 ACUTE MYELOID LEUKAEMIA 4 0.0003
729 HYPERKALAEMIA 9 0.0003
730 THERAPY PARTIAL RESPONDER 4 0.0003
731 BASAL CELL CARCINOMA 4 0.0003
732 AFFECTIVE DISORDER 2 0.0003
733 ABDOMINAL PAIN 59 0.0003
734 ARRHYTHMIA 12 0.0003
735 BACTERAEMIA 3 0.0003
736 MACULAR DEGENERATION 3 0.0003
737 VOMITING 118 0.0003
738 WOUND 7 0.0003
739 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
740 DECREASED APPETITE 58 0.0002
741 HIP FRACTURE 8 0.0002
742 BLOOD PRESSURE INCREASED 38 0.0002
743 BURSITIS 3 0.0002
744 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
745 BRADYCARDIA 13 0.0002
746 INJECTION SITE EXTRAVASATION 3 0.0002
747 PAIN IN EXTREMITY 71 0.0002
748 LIVER FUNCTION TEST ABNORMAL 7 0.0002
749 DRY EYE 12 0.0002
750 RASH PRURITIC 13 0.0002
751 URINARY RETENTION 8 0.0002
752 SECRETION DISCHARGE 3 0.0002
753 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
754 FALL 79 0.0002
755 RENAL DISORDER 11 0.0002
756 EATING DISORDER 5 0.0002
757 ROTATOR CUFF SYNDROME 3 0.0002
758 MUSCULOSKELETAL DISCOMFORT 4 0.0002
759 HAEMATOMA 6 0.0002
760 DIARRHOEA 149 0.0002
761 SWELLING FACE 15 0.0002
762 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
763 NODULE 3 0.0002
764 SEPTIC SHOCK 10 0.0002
765 DISCOMFORT 14 0.0002
766 DEAFNESS 6 0.0002
767 RASH MACULAR 8 0.0002
768 PULMONARY CONGESTION 3 0.0002
769 RASH MACULO-PAPULAR 5 0.0002
770 GOUT 4 0.0002
771 ACUTE KIDNEY INJURY 34 0.0002
772 PERIPHERAL SWELLING 34 0.0002
773 TACHYPNOEA 3 0.0002
774 HYPOTENSION 44 0.0002
775 SHOCK 5 0.0002
776 TREATMENT FAILURE 18 0.0002
777 NAUSEA 170 0.0002
778 EPISTAXIS 16 0.0002
779 OVERDOSE 46 0.0002
780 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
781 CARDIAC FAILURE 17 0.0002
782 CARDIAC FAILURE CONGESTIVE 17 0.0002
783 FUNGAL INFECTION 7 0.0002
784 MUSCULOSKELETAL PAIN 11 0.0002
785 CONVULSION 12 0.0002
786 NEOPLASM MALIGNANT 14 0.0002
787 SUBDURAL HAEMATOMA 3 0.0002
788 PARALYSIS 3 0.0002
789 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
790 PRESYNCOPE 5 0.0002
791 NEURALGIA 5 0.0002
792 GASTROENTERITIS 3 0.0002
793 HAEMATURIA 7 0.0002
794 URTICARIA 34 0.0002
795 ABASIA 5 0.0002
796 PNEUMONIA ASPIRATION 5 0.0002
797 PREMATURE BABY 6 0.0002
798 ANAPHYLACTIC REACTION 11 0.0002
799 THROMBOSIS 16 0.0002
800 FATIGUE 154 0.0002
801 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
802 HEPATITIS 5 0.0002
803 DEVICE RELATED INFECTION 3 0.0002
804 MYALGIA 33 0.0002
805 RESPIRATORY TRACT INFECTION 5 0.0002
806 TACHYCARDIA 17 0.0002
807 CYANOSIS 3 0.0002
808 PRODUCTIVE COUGH 9 0.0002
809 DYSGEUSIA 14 0.0002
810 SCIATICA 3 0.0002
811 INJECTION SITE BRUISING 15 0.0002
812 BREAST CANCER FEMALE 5 0.0002
813 INTESTINAL OBSTRUCTION 7 0.0002
814 LIMB INJURY 5 0.0002
815 PALLOR 5 0.0002
816 DIABETES MELLITUS 14 0.0002
817 VENTRICULAR TACHYCARDIA 3 0.0002
818 MOBILITY DECREASED 13 0.0002
819 ABDOMINAL DISCOMFORT 30 0.0002
820 BLISTER 10 0.0002
821 OXYGEN SATURATION DECREASED 10 0.0002
822 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
823 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
824 GASTRIC DISORDER 6 0.0002
825 OROPHARYNGEAL PAIN 16 0.0002
826 NEEDLE ISSUE 5 0.0002
827 COGNITIVE DISORDER 8 0.0002
828 NEUROTOXICITY 3 0.0002
829 HEART RATE DECREASED 6 0.0002
830 ERYTHEMA 35 0.0002
831 LYMPHOCYTE COUNT DECREASED 3 0.0002
832 COMA 8 0.0002
833 CEREBRAL HAEMORRHAGE 6 0.0002
834 ACCIDENT 2 0.0002
835 HYPERSENSITIVITY 31 0.0002
836 HEPATIC CANCER 4 0.0002
837 GASTROENTERITIS VIRAL 3 0.0002
838 PELVIC PAIN 3 0.0002
839 CORONARY ARTERY DISEASE 5 0.0002
840 RESTLESS LEGS SYNDROME 3 0.0002
841 MALAISE 72 0.0002
842 COUGH 46 0.0002
843 HYPERHIDROSIS 21 0.0002
844 ENCEPHALOPATHY 4 0.0002
845 NECK PAIN 9 0.0002
846 HEADACHE 100 0.0002
847 ARTHRALGIA 66 0.0002
848 DIZZINESS 79 0.0002
849 COLITIS 6 0.0002
850 ABDOMINAL PAIN LOWER 4 0.0002
851 MUSCULOSKELETAL DISORDER 3 0.0002
852 FEELING JITTERY 3 0.0002
853 CHOLESTASIS 3 0.0002
854 LOWER LIMB FRACTURE 3 0.0002
855 THERAPY NON-RESPONDER 7 0.0002
856 RASH GENERALISED 4 0.0002
857 DYSPNOEA 87 0.0002
858 VISION BLURRED 21 0.0002
859 SINUS DISORDER 3 0.0002
860 DEPRESSED MOOD 8 0.0002
861 CYTOKINE RELEASE SYNDROME 3 0.0001
862 SOMNOLENCE 30 0.0001
863 CONDITION AGGRAVATED 45 0.0001
864 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
865 DIVERTICULITIS 4 0.0001
866 CARDIO-RESPIRATORY ARREST 6 0.0001
867 RHEUMATOID ARTHRITIS 16 0.0001
868 URINARY TRACT INFECTION 24 0.0001
869 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
870 POOR QUALITY SLEEP 3 0.0001
871 PRURITUS GENERALISED 3 0.0001
872 DRUG INTERACTION 22 0.0001
873 TREMOR 23 0.0001
874 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
875 OFF LABEL USE 120 0.0001
876 DYSPHONIA 8 0.0001
877 ABDOMINAL PAIN UPPER 28 0.0001
878 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
879 INSOMNIA 36 0.0001
880 STEVENS-JOHNSON SYNDROME 3 0.0001
881 TRANSAMINASES INCREASED 3 0.0001
882 GLOSSODYNIA 3 0.0001
883 PANCREATITIS ACUTE 3 0.0001
884 RASH 58 0.0001
885 DYSARTHRIA 5 0.0001
886 LACRIMATION INCREASED 4 0.0001
887 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
888 WEIGHT INCREASED 29 0.0001
889 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
890 INJECTION SITE ERYTHEMA 16 0.0001
891 DEPRESSION 29 0.0001
892 ARTHRITIS 10 0.0001
893 DISORIENTATION 5 0.0001
894 CYSTITIS 4 0.0001
895 HYPOTHYROIDISM 4 0.0001
896 EYE PAIN 7 0.0001
897 AGITATION 9 0.0001
898 DEATH 104 0.0001
899 CARDIOVASCULAR DISORDER 3 0.0001
900 BALANCE DISORDER 10 0.0001
901 THERAPEUTIC RESPONSE DECREASED 7 0.0001
902 GAIT DISTURBANCE 22 0.0001
903 MUSCULAR WEAKNESS 13 0.0001
904 NASOPHARYNGITIS 21 0.0001
905 FEAR 3 0.0001
906 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
907 HEART RATE INCREASED 11 0.0001
908 AGRANULOCYTOSIS 2 0.0001
909 EMOTIONAL DISTRESS 13 0.0001
910 DISEASE RECURRENCE 5 0.0001
911 DRUG INEFFECTIVE 138 0.0001
912 ANGINA PECTORIS 3 0.0001
913 HYPERSOMNIA 3 0.0001
914 ACUTE RESPIRATORY FAILURE 2 0.0001
915 MYOCARDIAL INFARCTION 18 0.0001
916 DYSSTASIA 3 0.0001
917 MUSCULOSKELETAL STIFFNESS 9 0.0001
918 LUNG DISORDER 5 0.0001
919 PRODUCT USE ISSUE 19 0.0001
920 JOINT SWELLING 12 0.0001
921 CARDIAC ARREST 8 0.0001
922 SWOLLEN TONGUE 3 0.0001
923 HAEMORRHAGE 10 0.0001
924 HEAD INJURY 3 0.0001
925 LOSS OF CONSCIOUSNESS 12 0.0001
926 HYPOACUSIS 4 0.0001
927 ALOPECIA 18 0.0001
928 LIP SWELLING 3 0.0001
929 ARTHROPATHY 5 0.0001
930 SKIN DISORDER 3 0.0001
931 TINNITUS 4 0.0001
932 SKIN DISCOLOURATION 4 0.0001
933 SLEEP DISORDER 6 0.0001
934 IRRITABILITY 5 0.0001
935 CEREBROVASCULAR ACCIDENT 14 0.0001
936 VERTIGO 5 0.0001
937 PRURITUS 31 0.0001
938 FLUID RETENTION 4 0.0001
939 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
940 ANAPHYLACTIC SHOCK 2 0.0001
941 AMNESIA 5 0.0001
942 ECZEMA 4 0.0001
943 PANCREATITIS 4 0.0001
944 ABORTION SPONTANEOUS 3 0.0001
945 DYSKINESIA 3 0.0001
946 LUNG NEOPLASM MALIGNANT 3 0.0001
947 INJECTION SITE REACTION 5 0.0001
948 VISUAL IMPAIRMENT 9 0.0001
949 HAEMATOCHEZIA 4 0.0001
950 ABNORMAL DREAMS 2 0.0001
951 MEDICATION ERROR 4 0.0001
952 RHABDOMYOLYSIS 3 0.0001
953 BURNING SENSATION 5 0.0001
954 DYSPEPSIA 7 0.0001
955 SKIN EXFOLIATION 6 0.0001
956 NASAL CONGESTION 4 0.0001
957 HALLUCINATION 5 0.0001
958 EXPOSURE DURING PREGNANCY 4 0.0001
959 RENAL CANCER 3 0.0001
960 RASH ERYTHEMATOUS 3 0.0001
961 FEELING ABNORMAL 15 0.0001
962 HYPOGLYCAEMIA 3 0.0001
963 PALPITATIONS 7 0.0001
964 HEPATIC ENZYME INCREASED 4 0.0001
965 CHEST DISCOMFORT 6 0.0001
966 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
967 DRUG EFFECT DECREASED 3 0.0001
968 UNDERDOSE 4 0.0001
969 SUICIDAL IDEATION 5 0.0001
970 ASTHMA 6 0.0001
971 HOT FLUSH 4 0.0001
972 FLATULENCE 3 0.0001
973 CHRONIC KIDNEY DISEASE 4 0.0001
974 COVID-19 9 0.0001
975 WHEEZING 3 0.0001
976 ABNORMAL BEHAVIOUR 2 0.0001
977 ILL-DEFINED DISORDER 3 0.0000
978 DRY MOUTH 4 0.0000
979 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
980 RHINORRHOEA 3 0.0000
981 PSORIASIS 6 0.0000
982 INJECTION SITE PAIN 14 0.0000
983 ANGIOEDEMA 2 0.0000
984 MEMORY IMPAIRMENT 6 0.0000
985 ADVERSE EVENT 4 0.0000
986 AGGRESSION 2 0.0000
987 ACNE 3 0.0000
988 HOSPITALISATION 6 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
990 COMPLETED SUICIDE 3 0.0000
991 SEIZURE 4 0.0000
992 CARDIAC DISORDER 3 0.0000
993 DRY SKIN 4 0.0000
994 ADVERSE DRUG REACTION 2 0.0000
995 BLOOD GLUCOSE INCREASED 4 0.0000
996 TOXICITY TO VARIOUS AGENTS 3 0.0000